Tag: ATTR amyloidosis

19-CCC-6018-top10Innov-2019-3_650x450

No. 3 Medical Innovation for 2020: Inaugural Medication for Transthyretin Amyloid Cardiomyopathy

Tafamidis is first FDA-approved drug to treat potentially fatal disease

18-HRT-5612 cardiac-amyloidosis-650×450

Major Advances Are Afoot in Management of ATTR Cardiac Amyloidosis

New drugs, diagnostic tools are starting to revolutionize care

BackPage 1 of 1Next
Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Ad